JPWO2019208797A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019208797A5
JPWO2019208797A5 JP2020515615A JP2020515615A JPWO2019208797A5 JP WO2019208797 A5 JPWO2019208797 A5 JP WO2019208797A5 JP 2020515615 A JP2020515615 A JP 2020515615A JP 2020515615 A JP2020515615 A JP 2020515615A JP WO2019208797 A5 JPWO2019208797 A5 JP WO2019208797A5
Authority
JP
Japan
Prior art keywords
oxy
azetidin
carboxylic acid
hydroxy
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020515615A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019208797A1 (ja
JP7360132B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/018011 external-priority patent/WO2019208797A1/ja
Publication of JPWO2019208797A1 publication Critical patent/JPWO2019208797A1/ja
Publication of JPWO2019208797A5 publication Critical patent/JPWO2019208797A5/ja
Priority to JP2023156567A priority Critical patent/JP7598594B2/ja
Application granted granted Critical
Publication of JP7360132B2 publication Critical patent/JP7360132B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020515615A 2018-04-27 2019-04-26 オキソ置換化合物 Active JP7360132B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023156567A JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018087761 2018-04-27
JP2018087761 2018-04-27
PCT/JP2019/018011 WO2019208797A1 (ja) 2018-04-27 2019-04-26 オキソ置換化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023156567A Division JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Publications (3)

Publication Number Publication Date
JPWO2019208797A1 JPWO2019208797A1 (ja) 2021-05-27
JPWO2019208797A5 true JPWO2019208797A5 (cg-RX-API-DMAC10.html) 2023-02-15
JP7360132B2 JP7360132B2 (ja) 2023-10-12

Family

ID=68295570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020515615A Active JP7360132B2 (ja) 2018-04-27 2019-04-26 オキソ置換化合物
JP2023156567A Active JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023156567A Active JP7598594B2 (ja) 2018-04-27 2023-09-21 オキソ置換化合物

Country Status (15)

Country Link
US (3) US11702431B2 (cg-RX-API-DMAC10.html)
EP (1) EP3786168A4 (cg-RX-API-DMAC10.html)
JP (2) JP7360132B2 (cg-RX-API-DMAC10.html)
KR (1) KR102679411B1 (cg-RX-API-DMAC10.html)
CN (2) CN112135830B (cg-RX-API-DMAC10.html)
AU (1) AU2019259818B2 (cg-RX-API-DMAC10.html)
CA (1) CA3098433A1 (cg-RX-API-DMAC10.html)
EA (1) EA202092579A1 (cg-RX-API-DMAC10.html)
IL (1) IL278262B2 (cg-RX-API-DMAC10.html)
MX (1) MX2020011367A (cg-RX-API-DMAC10.html)
PH (1) PH12020551772A1 (cg-RX-API-DMAC10.html)
SG (1) SG11202010661SA (cg-RX-API-DMAC10.html)
TW (2) TWI829686B (cg-RX-API-DMAC10.html)
UA (1) UA129150C2 (cg-RX-API-DMAC10.html)
WO (1) WO2019208797A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020138499A1 (ja) * 2018-12-28 2021-11-04 大日本住友製薬株式会社 アルキル置換化合物
US20230038124A1 (en) * 2019-10-25 2023-02-09 Sumitomo Pharma Co., Ltd. Novel substituted condensed ring compound
US11476003B2 (en) * 2020-12-15 2022-10-18 Biodesix, Inc. Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
JPWO2024128238A1 (cg-RX-API-DMAC10.html) 2022-12-13 2024-06-20

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201000774A1 (ru) * 2007-11-13 2010-12-30 Новартис Интернэшнл Фармасьютикл Лтд. Ингибиторы бета-лактамазы
JP6403219B2 (ja) 2012-12-07 2018-10-10 ベナトルクス ファーマシューティカルズ,インク. ベータ−ラクタマーゼ阻害剤
KR20150103270A (ko) * 2013-01-04 2015-09-09 렘펙스 파머수티클스 인코퍼레이티드 보론산 유도체 및 그의 치료적 용도
AU2014204045B2 (en) 2013-01-04 2018-10-18 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN105101970B (zh) 2013-01-10 2018-11-20 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
WO2014151958A1 (en) 2013-03-14 2014-09-25 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
AU2015264418A1 (en) * 2014-05-19 2016-11-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
KR102396753B1 (ko) 2014-06-11 2022-05-12 베나토알엑스 파마슈티컬스, 인크. 베타-락타마제 억제제
AU2015284307A1 (en) 2014-07-01 2017-02-02 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016149393A1 (en) 2015-03-17 2016-09-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
EP3347008B1 (en) 2015-09-11 2022-03-09 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors

Similar Documents

Publication Publication Date Title
JP4302762B2 (ja) 複素環式芳香族キノリン化合物およびpde10阻害剤としてのその使用
US9403830B2 (en) Inhibitors of leukotriene production
US8841295B2 (en) 5-lipoxygenase-activating protein (FLAP) inhibitors
SA516371614B1 (ar) مركبات أزا حلقية ثنائية كمحفزات لمستقبل m1 و/أو مستقبل m4 مسكريني
RU2006127573A (ru) Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата
US20050009843A1 (en) Medicine for inhibiting drug elimination pump
USRE49700E1 (en) Substituted nitrogen containing compounds
JP2018534328A5 (cg-RX-API-DMAC10.html)
US12590091B2 (en) 1H-pyrrolo[3,2-C]pyridine and 1H-pyrrolo[2,3-C]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
JP2007523182A5 (cg-RX-API-DMAC10.html)
CA3042684A1 (en) Azole amides and amines as .alpha.v integrin inhibitors
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
HRP20211678T1 (hr) N-supstituirani derivati indola kao modulatori receptora pge2
AU2017359023A1 (en) 3-substituted propionic acids as alpha v integrin inhibitors
JP2023526841A (ja) ピペラジン環状尿素類
US10407422B2 (en) Triazolopyridine inhibitors of myeloperoxidase
IL295506A (en) Heterocyclic pad4 inhibitors
US20230295145A1 (en) Pyrrolidine derivatives and methods of use
US20230322770A1 (en) Substituted heteroaryl compounds useful as inhibitors of tlr9
US20060106034A1 (en) Drug efflux pump inhibitor
US20200024272A1 (en) 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ror1 activity
TW202444385A (zh) Egfr降解劑、其藥物組成物及其用途
ES2328225T3 (es) Derivados benzoheterociclicos inhibidores de la farnesil-transferasa.
JPS59196895A (ja) 6−(ヒドロキシアルキル)−2−(ヘテロアリ−ルアルキルチオ)ペネム類、それらの製造方法およびそれらを含む医薬組成物
JPS59231091A (ja) 7−オキソ−4−チア−1−アザビシクロ〔3.2.0〕ヘプタ−2−エン誘導体